Episode 8: Breaking Barriers in Clinical Trials - Paul Evans, CEO of Velocity Clinical Research
Watch on your preferred podcast app
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 26 27" xmlns="http://www.w3.org/2000/svg"><defs ><linearGradient id="WpGR3HcvE-3808260456-linear-gradient" x1="0.49751243781094523" x2="0.5024875621890548" y1="0" y2="1"><stop offset="0" stop-color="rgb(244, 82, 255)"/><stop offset="1" stop-color="rgb(131, 43, 193)"/></linearGradient></defs><g d="M 0 0 L 25 0 L 25 25 L 0 25 Z M 24.508 21.667 C 24.267 22.283 23.708 23.15 22.908 23.767 C 22.45 24.117 21.9 24.458 21.15 24.683 C 20.35 24.925 19.358 25 18.125 25 L 6.875 25 C 5.642 25 4.658 24.917 3.85 24.683 C 3.1 24.458 2.55 24.125 2.092 23.767 C 1.3 23.158 0.733 22.283 0.492 21.667 C 0.008 20.425 0 19.017 0 18.125 L 0 6.875 C 0 5.983 0.008 4.575 0.492 3.333 C 0.733 2.717 1.292 1.85 2.092 1.233 C 2.55 0.883 3.1 0.542 3.85 0.317 C 4.658 0.083 5.642 0 6.875 0 L 18.125 0 C 19.358 0 20.342 0.083 21.15 0.317 C 21.9 0.542 22.45 0.875 22.908 1.233 C 23.7 1.842 24.267 2.717 24.508 3.333 C 25 4.575 25 5.992 25 6.875 L 25 18.125 C 25 19.017 24.992 20.425 24.508 21.667 Z M 14.642 15.092 C 14.608 14.791 14.508 14.575 14.308 14.375 C 13.933 13.983 13.275 13.725 12.5 13.725 C 11.725 13.725 11.067 13.975 10.692 14.375 C 10.5 14.583 10.392 14.791 10.358 15.091 C 10.292 15.675 10.333 16.175 10.4 16.983 C 10.467 17.75 10.592 18.775 10.75 19.808 C 10.867 20.55 10.958 20.95 11.042 21.233 C 11.183 21.7 11.692 22.1 12.5 22.1 C 13.308 22.1 13.825 21.691 13.958 21.233 C 14.042 20.95 14.133 20.55 14.25 19.808 C 14.408 18.766 14.533 17.75 14.6 16.983 C 14.675 16.175 14.708 15.675 14.642 15.091 Z M 14.55 10.842 C 14.55 11.385 14.334 11.907 13.95 12.291 C 13.565 12.676 13.044 12.892 12.5 12.891 C 11.956 12.892 11.435 12.676 11.05 12.291 C 10.665 11.907 10.45 11.385 10.45 10.841 C 10.45 10.298 10.665 9.776 11.05 9.391 C 11.435 9.007 11.956 8.791 12.5 8.791 C 13.633 8.791 14.55 9.716 14.55 10.841 Z M 12.475 2.767 C 7.692 2.783 3.775 6.667 3.708 11.45 C 3.658 15.325 6.133 18.642 9.592 19.858 C 9.675 19.892 9.758 19.817 9.75 19.733 C 9.708 19.433 9.658 19.133 9.625 18.833 C 9.608 18.73 9.543 18.64 9.45 18.592 C 6.717 17.4 4.808 14.658 4.842 11.483 C 4.883 7.317 8.283 3.925 12.442 3.892 C 16.7 3.858 20.175 7.308 20.175 11.558 C 20.175 14.7 18.275 17.4 15.567 18.592 C 15.467 18.632 15.399 18.726 15.392 18.833 L 15.267 19.733 C 15.25 19.825 15.342 19.892 15.425 19.858 C 18.85 18.658 21.308 15.392 21.308 11.558 C 21.292 6.708 17.333 2.758 12.475 2.767 Z M 12.275 5.683 C 9.158 5.8 6.658 8.375 6.617 11.492 C 6.592 13.542 7.617 15.358 9.192 16.433 C 9.267 16.483 9.375 16.425 9.375 16.333 C 9.351 15.998 9.349 15.661 9.367 15.325 C 9.375 15.217 9.332 15.112 9.25 15.042 C 8.256 14.112 7.707 12.802 7.742 11.442 C 7.808 8.942 9.817 6.908 12.317 6.808 C 15.033 6.7 17.267 8.883 17.267 11.567 C 17.267 12.933 16.683 14.167 15.758 15.042 C 15.683 15.117 15.641 15.219 15.642 15.325 C 15.658 15.65 15.65 15.967 15.633 16.325 C 15.625 16.417 15.733 16.483 15.817 16.425 C 17.367 15.367 18.392 13.575 18.392 11.558 C 18.4 8.242 15.625 5.55 12.275 5.683 Z" fill="transparent" height="25px" id="eaTjxwiak" transform="translate(0.5 1)" width="25px"><path d="M 0 0 L 25 0 L 25 25 L 0 25 Z" fill="transparent" height="25px" id="PesPdGeRu" width="25px"/><path d="M 24.508 21.667 C 24.267 22.283 23.708 23.15 22.908 23.767 C 22.45 24.117 21.9 24.458 21.15 24.683 C 20.35 24.925 19.358 25 18.125 25 L 6.875 25 C 5.642 25 4.658 24.917 3.85 24.683 C 3.1 24.458 2.55 24.125 2.092 23.767 C 1.3 23.158 0.733 22.283 0.492 21.667 C 0.008 20.425 0 19.017 0 18.125 L 0 6.875 C 0 5.983 0.008 4.575 0.492 3.333 C 0.733 2.717 1.292 1.85 2.092 1.233 C 2.55 0.883 3.1 0.542 3.85 0.317 C 4.658 0.083 5.642 0 6.875 0 L 18.125 0 C 19.358 0 20.342 0.083 21.15 0.317 C 21.9 0.542 22.45 0.875 22.908 1.233 C 23.7 1.842 24.267 2.717 24.508 3.333 C 25 4.575 25 5.992 25 6.875 L 25 18.125 C 25 19.017 24.992 20.425 24.508 21.667 Z" fill="url(%23WpGR3HcvE-3808260456-linear-gradient)" height="25px" id="WpGR3HcvE" width="25px"/><path d="M 4.317 6.3 C 4.284 6 4.184 5.783 3.984 5.583 C 3.609 5.192 2.95 4.933 2.175 4.933 C 1.4 4.933 0.742 5.183 0.367 5.583 C 0.175 5.792 0.067 6 0.034 6.3 C -0.033 6.883 0.009 7.383 0.075 8.192 C 0.142 8.958 0.267 9.983 0.425 11.017 C 0.542 11.758 0.634 12.158 0.717 12.442 C 0.859 12.908 1.367 13.308 2.175 13.308 C 2.984 13.308 3.5 12.9 3.634 12.442 C 3.717 12.158 3.809 11.758 3.925 11.017 C 4.084 9.975 4.209 8.958 4.275 8.192 C 4.35 7.383 4.384 6.883 4.317 6.3 Z M 4.225 2.05 C 4.226 2.594 4.01 3.116 3.625 3.5 C 3.241 3.885 2.719 4.1 2.175 4.1 C 1.632 4.1 1.11 3.885 0.725 3.5 C 0.341 3.115 0.125 2.594 0.125 2.05 C 0.125 1.506 0.341 0.985 0.725 0.6 C 1.11 0.215 1.632 0 2.175 0 C 3.309 0 4.225 0.925 4.225 2.05 Z" fill="rgb(255, 255, 255)" height="13.308333873748765px" id="Dh9clhvby" transform="translate(10.325 8.791)" width="4.352992888060516px"/><path d="M 8.767 0 C 3.984 0.017 0.067 3.9 0.001 8.683 C -0.049 12.558 2.426 15.875 5.884 17.092 C 5.967 17.125 6.051 17.05 6.042 16.967 C 6.001 16.667 5.951 16.367 5.917 16.067 C 5.901 15.963 5.836 15.873 5.742 15.825 C 3.009 14.633 1.101 11.892 1.134 8.717 C 1.176 4.55 4.576 1.158 8.734 1.125 C 12.992 1.092 16.467 4.542 16.467 8.792 C 16.467 11.933 14.567 14.633 11.859 15.825 C 11.76 15.866 11.692 15.959 11.684 16.067 L 11.559 16.967 C 11.542 17.058 11.634 17.125 11.717 17.092 C 15.142 15.892 17.601 12.625 17.601 8.792 C 17.584 3.942 13.626 -0.008 8.767 0 Z" fill="rgb(255, 255, 255)" height="17.100397740075255px" id="TAjtw1igw" transform="translate(3.708 2.767)" width="17.600744064163877px"/><path d="M 5.659 0.005 C 2.542 0.121 0.042 2.696 0 5.813 C -0.025 7.863 1 9.68 2.575 10.755 C 2.65 10.805 2.759 10.746 2.759 10.655 C 2.735 10.319 2.732 9.982 2.75 9.646 C 2.759 9.539 2.716 9.434 2.634 9.363 C 1.64 8.434 1.091 7.123 1.125 5.763 C 1.192 3.263 3.2 1.23 5.7 1.13 C 8.417 1.021 10.65 3.205 10.65 5.888 C 10.65 7.255 10.067 8.488 9.142 9.363 C 9.067 9.438 9.025 9.54 9.025 9.646 C 9.042 9.971 9.034 10.288 9.017 10.646 C 9.009 10.738 9.117 10.805 9.2 10.746 C 10.75 9.688 11.775 7.896 11.775 5.88 C 11.784 2.563 9.009 -0.129 5.659 0.005 Z" fill="rgb(255, 255, 255)" height="10.773110810436085px" id="YDJbOoTts" transform="translate(6.616 5.679)" width="11.77546599576002px"/></g></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 26 27" xmlns="http://www.w3.org/2000/svg"><g d="M 0 0 L 25 0 L 25 25 L 0 25 Z M 21.25 0 L 3.75 0 C 1.679 0 0 1.678 0 3.75 L 0 21.25 C 0 23.321 1.679 25 3.75 25 L 21.25 25 C 23.321 25 25 23.321 25 21.25 L 25 3.75 C 25 1.679 23.321 0 21.25 0 Z M 12.5 3.125 C 17.678 3.125 21.875 7.322 21.875 12.5 C 21.875 17.678 17.678 21.875 12.5 21.875 C 7.322 21.875 3.125 17.678 3.125 12.5 C 3.125 7.322 7.322 3.125 12.5 3.125 Z M 16.616 15.855 C 13.291 13.872 9.995 14.253 7.495 14.809 C 7.343 14.843 7.211 14.935 7.128 15.066 C 7.044 15.197 7.017 15.356 7.051 15.508 C 7.084 15.66 7.177 15.792 7.308 15.875 C 7.439 15.959 7.597 15.987 7.749 15.952 C 10.034 15.444 13.042 15.088 16.011 16.86 C 16.104 16.919 16.206 16.943 16.309 16.943 L 16.318 16.948 C 16.519 16.948 16.714 16.846 16.821 16.66 C 16.987 16.381 16.895 16.021 16.616 15.855 Z M 12.49 11.392 C 10.708 11.216 8.838 11.367 7.222 11.816 C 6.819 11.928 6.583 12.346 6.694 12.749 C 6.806 13.152 7.224 13.388 7.627 13.276 C 10.239 12.549 14.131 12.603 16.934 14.36 C 17.056 14.438 17.198 14.477 17.334 14.477 L 17.339 14.477 C 17.588 14.477 17.837 14.351 17.978 14.121 C 18.198 13.765 18.095 13.296 17.739 13.076 C 16.289 12.168 14.473 11.587 12.49 11.392 Z M 12.798 8.15 C 10.747 7.969 8.623 8.149 6.665 8.672 C 6.439 8.73 6.245 8.876 6.128 9.078 C 6.01 9.28 5.979 9.52 6.04 9.746 C 6.098 9.972 6.244 10.166 6.446 10.283 C 6.648 10.401 6.889 10.433 7.114 10.371 C 8.914 9.897 10.783 9.739 12.637 9.902 C 14.619 10.078 16.455 10.606 18.095 11.47 C 18.227 11.538 18.369 11.572 18.506 11.572 L 18.511 11.567 C 18.823 11.567 19.131 11.397 19.287 11.099 C 19.397 10.893 19.42 10.652 19.351 10.429 C 19.283 10.206 19.128 10.02 18.921 9.912 C 17.075 8.94 15.015 8.345 12.798 8.15 Z" fill="transparent" height="25px" id="pE39QW8MG" transform="translate(0.5 1)" width="25px"><path d="M 0 0 L 25 0 L 25 25 L 0 25 Z" fill="transparent" height="25px" id="JjUzgLBhV" width="25px"/><path d="M 21.25 0 L 3.75 0 C 1.679 0 0 1.678 0 3.75 L 0 21.25 C 0 23.321 1.679 25 3.75 25 L 21.25 25 C 23.321 25 25 23.321 25 21.25 L 25 3.75 C 25 1.679 23.321 0 21.25 0 Z" fill="rgb(59, 215, 95)" height="25px" id="BFWXQOnUV" width="25px"/><path d="M 9.375 0 C 14.553 0 18.75 4.197 18.75 9.375 C 18.75 14.553 14.553 18.75 9.375 18.75 C 4.197 18.75 0 14.553 0 9.375 C 0 4.197 4.197 0 9.375 0 Z M 13.491 12.73 C 10.166 10.747 6.87 11.128 4.37 11.684 C 4.218 11.718 4.086 11.81 4.003 11.941 C 3.919 12.072 3.892 12.231 3.926 12.383 C 3.959 12.535 4.052 12.667 4.183 12.75 C 4.314 12.834 4.472 12.862 4.624 12.827 C 6.909 12.319 9.917 11.963 12.886 13.735 C 12.979 13.794 13.081 13.818 13.184 13.818 L 13.193 13.823 C 13.394 13.823 13.589 13.721 13.696 13.535 C 13.862 13.256 13.77 12.896 13.491 12.73 Z M 9.365 8.267 C 7.583 8.091 5.713 8.242 4.097 8.691 C 3.694 8.803 3.458 9.221 3.569 9.624 C 3.681 10.027 4.099 10.263 4.502 10.151 C 7.114 9.424 11.006 9.478 13.809 11.235 C 13.931 11.313 14.073 11.352 14.209 11.352 L 14.214 11.352 C 14.463 11.352 14.712 11.226 14.853 10.996 C 15.073 10.64 14.97 10.171 14.614 9.951 C 13.164 9.043 11.348 8.462 9.365 8.267 Z M 9.673 5.025 C 7.622 4.844 5.498 5.024 3.54 5.547 C 3.314 5.605 3.12 5.751 3.003 5.953 C 2.885 6.155 2.854 6.395 2.915 6.621 C 2.973 6.847 3.119 7.041 3.321 7.158 C 3.523 7.276 3.764 7.308 3.989 7.246 C 5.789 6.772 7.658 6.614 9.512 6.777 C 11.494 6.953 13.33 7.481 14.97 8.345 C 15.102 8.413 15.244 8.447 15.381 8.447 L 15.386 8.442 C 15.698 8.442 16.006 8.272 16.162 7.974 C 16.272 7.768 16.295 7.527 16.226 7.304 C 16.158 7.081 16.003 6.895 15.796 6.787 C 13.95 5.815 11.89 5.22 9.673 5.025 Z" fill="rgb(255, 255, 255)" height="18.75px" id="kxioXza8e" transform="translate(3.125 3.125)" width="18.75px"/></g></svg>)
Paul Evans, CEO of Velocity Clinical Research, joins Patty to discuss the evolution of clinical trial sites, the challenges of patient recruitment, and the impact of technology on research efficiency. From his early days in Wales to leading one of the most prominent site networks, Paul shares insights on the industry’s biggest hurdles—and what the future holds.
Start your next trial faster with higher quality and compliance.
Our team is ready to support your unique needs. Schedule a demo today.